Objectives：This study aimed to determine whether or not signal intensity caused by the contrast effects of Contrastenhanced ultrasonography (CEUS) using perflubutane could predict malignancy grades of invasive breast cancer.
nuclear grade, Ki-67) in breast cancer.
Results：Time to washout of time required to reach plateau intensity from the start of the maximum intensity was significantly associated with the Ki-67 value (p = 0.03). Also, A parameter of intratumoral blood perfusion, peak intensity (PI), was significantly associated with the Ki-67 value (p = 0.006) and ER status (p = 0.002) ( Also, Thirty-eight, 7, and 9 patients had luminal, HER-2-positive and triple-negative tumors, respectively. The PI values for these tumors were 56.8 ± 20.9, 71.9 ± 20.5, and 85.7 ± 23.2, respectively. And, the PI value was significantly greater in the triple-negative, than in luminal tumors (p = 0.001).
Table2. Relationship between signal intensity as a perfusion parameter and tumor subtypes
Tumor subtype n Peak intensity (Mean ± SD) P value * Luminal 38 56.8 ± 20.9
HER-2-positive 7 71.9 ± 20.5 0.09
Triple-negative 9 85.7 ± 23.2 0.001 *) p value vs. Luminal PI Furthermore, PI significantly correlated with the Ki-67 value (Spearman r = 0.54, p = 0.00002).
Conclusions：These findings indicated that PI has excellent predictive value for grade malignancy in breast cancer and might help to determine appropriate therapeutic strategies.
Key points：
·Contrast-enhanced ultrasonography (CEUS) enables the real-time evaluation of detailed hemodynamics in breast cancer.
·Peak intensity (PI) was significantly associated with Estrogen Receptors and Ki-67 assessed by immunohistochemistry.
·PI significantly correlated with the Ki-67 value, indicating that PI reflects the grade of proliferative activity in tumors.
·Analyses of contrast-effect intensity will be applied to evaluate grades of malignancy and determine treatment strategies.
